Show Stocks and Investing Publications • Fri, November 11, 2022
Emmanuel Papadakis Maintained (BNTX) at Hold with Decreased Target to $160 on, Nov 11th, 2022
s-maintained-bntx-at-hold-with-decreased-target-to-160-on-nov-11th-2022.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIEmmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $180 to $160 on, Nov 11th, 2022.
Emmanuel has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $177 on, Tuesday, November 8th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $203 on, Tuesday, November 8th, 2022
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $132 on, Monday, October 24th, 2022
These are the ratings of the 2 analyists that currently disagree with Emmanuel
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $272 on, Wednesday, August 10th, 2022
- Daina Graybosch of "SVB Leerink" Maintained at Buy with Increased Target to $224 on, Friday, July 29th, 2022
Like: 👍